Development and distribution of pharmaceutical formulations in India.
Annual revenue $87,382 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Hebert Biotech

Data last updated:

Hebert Biotech is a company. Hebert Biotech offers products and services including Gastro Products and Antibiotics.

Operational Areas
Healthcare β†’ Pharmaceuticals & Therapeutics → Unlock Sub-Sector → Unlock Segment
Healthcare β†’ Healthcare Products & Supplies → Unlock Sub-Sector → Unlock Segment
Key Metrics
  • Annual Revenue
    $87.38 K (USD)
    0
    as on Mar 31, 2021
  • Net Profit
    $1.33 K (USD)
    863.94
    as on Mar 31, 2021
  • EBITDA
    $2.01 K (USD)
    1280.83
    as on Mar 31, 2021
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Hebert Biotech

Hebert Biotech offers a comprehensive portfolio of products and services, including Gastro Products and Antibiotics.

Product name locked
Category locked
Primary

Gastro products are developed and marketed as formulations for gastrointestinal treatments and are distributed across India.

Product name locked
Category locked
Locked

Antibiotics are produced and supplied for treating various infections, forming part of the company's range of affordable generic and branded formulations.

Funding Insights of Hebert Biotech

Premium access

Detailed funding history for Hebert Biotech

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Hebert Biotech

Investments
Premium access

Investment portfolio details for Hebert Biotech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Hebert Biotech

Premium access

Detailed financials for Hebert Biotech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Hebert Biotech Comparisons

Hebert Biotech Primary company
Description
Development and distribution of pharmaceutical formulations ...
Location
-
Founded Year
-
Annual Revenue
$87.38 K (USD)
Net Profit
$1.33 K (USD)
EBITDA
$2.01 K (USD)
Employees
Not available
Premium access

Peer comparison for Hebert Biotech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Hebert Biotech

Premium access

Detailed competitors of Hebert Biotech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Hebert Biotech

Premium access

Complete news archive for Hebert Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hebert Biotech

Annual revenue of Hebert Biotech is $87.38K as on Mar 31, 2021.

Hebert Biotech Private Limited is identified as an emerging pharmaceutical company that has developed and distributed a wide array of quality generic and branded formulations across India. It is headquartered in New Delhi and focuses on integrating people, processes, and potential to enhance societal well-being through healthcare products such as gastro items, antibiotics, and womens care. Commitment to quality is demonstrated by adapting to changes and anticipating challenges, while success is measured by contributions to communities and work environments. Products are marketed affordably for multiple markets, emphasizing patient care and accessibility.

Hebert Biotech offers Gastro Products and Antibiotics.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available